Deferred Tax Assets, Valuation Allowance of Adverum Biotechnologies, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Adverum Biotechnologies, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Adverum Biotechnologies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $232,058,000, a 13% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Adverum Biotechnologies, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $232,058,000 +$26,197,000 +13% 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q4 2023 $205,861,000 +$17,720,000 +9.4% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $188,141,000 +$39,701,000 +27% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q4 2021 $148,440,000 +$53,795,000 +57% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q4 2020 $94,645,000 +$28,444,000 +43% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q4 2019 $66,201,000 +$18,947,000 +40% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q4 2018 $47,254,000 +$11,791,000 +33% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q4 2017 $35,463,000 +$12,063,000 +52% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q4 2016 $23,400,000 -$5,439,000 -19% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q4 2015 $28,839,000 +$16,382,000 +132% 31 Dec 2015 10-K 06 Mar 2018 2017 FY
Q4 2014 $12,457,000 +$9,920,000 +391% 31 Dec 2014 10-K 09 Mar 2017 2016 FY
Q4 2013 $2,537,000 +$1,446,000 +133% 31 Dec 2013 10-K 04 Mar 2016 2015 FY
Q4 2012 $1,091,000 31 Dec 2012 10-K 05 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.